Medicare AdvantageCoverageMedium impact
26-344m Part D Coverage of Insulin and Biosimilars
Health Net·CA · Endocrinology, Family Medicine, Internal Medicine +1 more·Provider News
Effective date
Mar 20, 2026
We identified it
Jun 20, 2026
Summary
HealthNet California has updated Part D coverage policies for insulin and biosimilar medications under Medicare Advantage Part D and Prescription Drug Plans. This policy affects prescription drug coverage and billing for diabetes-related medications.
Action Required
By March 20, 2026: Billing team should download and review the updated Part D insulin and biosimilars coverage flyer from HealthNet California provider library. Update prescription protocols and verify coverage requirements for insulin and biosimilar medications for Medicare Advantage Part D patients. Coordinate with pharmacy teams on any new coverage restrictions or requirements.